(Total Views: 300)
Posted On: 08/03/2022 1:44:04 PM
Post# of 8401
Like many others, I BIELieve that 25 Aug was selected for a very good reason and it has to do w/ RecoveryRx. There's too, too, much advertising/tweeting for it to lie dormant, or worse, remain unmentioned. This promotion is ongoing, informative, well designed and well-planned. My prediction (ha, like it means anything ... ) is we will hear good news about RecoveryRx on the shareholder update. There remains the possibility of having a pr release between Q2 numbers and the shareholder update.
FYI - I have three inquiries I would like addressed. The first is, drum roll please ..., the category I CPT insurance codes. Where do we stand and how is the process coming along? Any info would be appreciated.
The second is about manufacturing of product. Where are we w/ that in ref: to large scale production needed to fulfill domestic demand should we get accepted into CMMS/VA/DOD, Hospital Groups, Insurance coverage, etc.? And does Viant/Meraqi (Dr. Koneru) have anything to do w/ it?
Please comment about Allay, the pet market, plantar fasciitis, etc.
Q2 numbers and Aug 25th cannot come soon enough.
BUY_MORE_SHARES
later, WBeacham
FYI - I have three inquiries I would like addressed. The first is, drum roll please ..., the category I CPT insurance codes. Where do we stand and how is the process coming along? Any info would be appreciated.
The second is about manufacturing of product. Where are we w/ that in ref: to large scale production needed to fulfill domestic demand should we get accepted into CMMS/VA/DOD, Hospital Groups, Insurance coverage, etc.? And does Viant/Meraqi (Dr. Koneru) have anything to do w/ it?
Please comment about Allay, the pet market, plantar fasciitis, etc.
Q2 numbers and Aug 25th cannot come soon enough.
BUY_MORE_SHARES
later, WBeacham
(3)
(0)
